CClinicalTrials.gg
CompletedNCT04208737Updated Jun 9, 2020

Effects of Recruitment Maneuver on Functional Residual Capacity

An interventional study of recruitment maneuver in Anesthesia, Surgery and Atelectasis, sponsored by Istanbul University. Completed at 2 sites in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2020-06-09.

Sponsored by Istanbul University · Not applicable, Interventional, and Screening

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Recruitment maneuver is frequently used in daily anaesthesia routine to prevent athelectasia and ventilation perfusion mismatch. Especially pneumoperitoneum in laparoscopic surgeries affects the functional residual capacity (FRC) negatively. Recently, FRC can be measured at bedside in intensive care units.

The lack of studies evaluating FRC measurements peroperatively and how recruitment maneuvers affect it, attract attention.

Read the detailed description

An ICU-ventilator capable to measure the FRC will be used for the mechanical ventilation in patients undergıoing laparoscopic surgery, where anaesthesia maintenance will be achieved with TIVA.

FRC will be measured in different steps of the operation. In the study group, a recruitment manover will be applied to evaluate its effects on FRC.

02

Conditions studied

  • Anesthesia
  • Surgery
  • Atelectasis

Browse trials for

03

In context

Pulmonary Atelectasis

301 studies on the registry are indexed under Pulmonary Atelectasis; 80 are open to participants now.

This study's enrollment of 50 is below the median of 61 across 222 interventional studies indexed under Pulmonary Atelectasis.

Browse Pulmonary Atelectasis studies →

Lead sponsor

Istanbul University is the lead sponsor of 496 studies on the registry; 79 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

1-18-65 years age 2-no lung disease 3-laparoscopic cholecystectomies surgery

Exclusion criteria

Exclusion Criteria:

  1. \<18 years old
  2. >65 years old
  3. denial of patient
  4. patients having one of: lung disease, cardiac failure, severe cardiac valvular disease
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • No intervention
    control group

    3 FRC measurements will be perforemed, whereby : First measurement; after aneshesia induction and intubation. Second measurement; after pneumoperitoneum Third measurement; end of the operation After the operation,Postoperative Room Air Test (RAT) will be applied.

  • Experimental
    study group

    5 FRC measurements will be performed We will apply recruitment maneuver two times to patients with 30cmH2O pressure for 15 seconds . First Recruitment maneuver will be applied after the fşrst measurement of FRC following intubation Second Recuitment maneuver will be applied at the end of operation First FRC measurement after anesthesia induction and intubation. Second FRC measurement after first recruitment maneuver Third FRC measurement; after pneumoperitoneum Fourth FRC measurement before second recruitment maneuver Fifth FRC measurement after second recruitment maneuver and at the end of operation

    Procedure: recruitment maneuver

Interventions

  • Procedurerecruitment maneuver

    30 cmH2O pressure 15 seconds

06

What researchers measure

Primary outcomes

  1. Comparison of FRC measurements at beginning and end of anesthesia

    First FRC will be measured after ; the last FRC will be measure bedore the extubation

    Time frame: within max 5 minutes after the intubation and with max 5 minutes before the extubation

Secondary outcomes

  1. Positive room air test

    in recovery room when patient modified aldrete score ≥ 9 patient SPO2 when breathing in room air If patients' spo2 value ≤ 96%, named as room air test positive

    Time frame: in recovery room 30 minutes after operation

07

Study locations

2 sites
  • Istanbul University
    Istanbul, 34069, Turkey
  • Istanbul University, Department of Anesthesiology
    Istanbul, 34093, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 9, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04208737
Lead sponsor
Istanbul University
Responsible party
Nuzhet Mert Senturk, MD, Prof (Prof.Dr., Istanbul University) — Principal investigator
First posted
Dec 23, 2019
Start date
Dec 23, 2019
Primary completion
May 1, 2020
Completion
Jun 1, 2020
Last update
Jun 9, 2020

Study contacts

Elif Aygun, MD
principal investigator · Istanbul University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion